Authors: Brillanti, S Levantesi, F

Citation: S. Brillanti et F. Levantesi, What hides behind an intention-to-trea(t) analysis? Reply, HEPATOLOGY, 33(4), 2001, pp. 1014-1015

Authors: Brillanti, S Levantesi, F Masi, L Foli, M Bolondi, L

Citation: S. Brillanti et al., Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C, HEPATOLOGY, 32(3), 2000, pp. 630-634

Authors: Brillanti, S Foli, M Di Tomaso, M Gramantieri, L Masci, C Bolondi, L

Citation: S. Brillanti et al., Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders, ITAL J GAST, 31(2), 1999, pp. 130-134

Authors: Gramantieri, L Chieco, P Di Tomaso, M Masi, L Piscaglia, F Brillanti, S Gaiani, S Valgimigli, M Mazziotti, A Bolondi, L

Citation: L. Gramantieri et al., Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis, CLIN CANC R, 5(11), 1999, pp. 3468-3475